2024 Expert Speaker Faculty Andrew Young Chief Medical Officer i2o Therapeutics Harshita Ravishankar Lifesciences Partnerships Truveta Ibrahim Turfanda Senior Director, Next Generation Incretins, NILEX & Outcomes Eli Lilly & Company Jacek Mokrosinski Senior Scientist Novo Nordisk Jo Bednarik Executive Director, Medical Development, Diabetes, & Obesity Eli Lilly & Company Joseph Zabinski Vice President, Commercial Strategy & AI OM1 Inc Lars Johansson Chief Scientific Officer Antaros Medical Leilani Morales Head, Medical Development and Evidence Generation Roche Manu Chakravarthy Chief Scientific & Medical Officer Carmot Therapeutics MarieElena Cordisco Senior Director Therapeutic Strategy Lead, Metabolic Worldwide Clinical Trials Matthew Coghlan Vice President & Head Incretin Portfolio Science Eli Lilly & Company Michael Grimm Head of Metabolic Diseases Regor Therapeutics Mitchell Steiner Chief Executive Officer Veru Inc. Nita Thingalaya Senior Director, Medical Evidence Generation & Innovation Sanofi Paul Rubin Chief Medical Officer BioAge Labs Scott Harris Chief Medical Officer Altimmune Seulki Lee Chief Executive Officer D&D Pharmatech Todd Hobbs Chief Medical Officer Diasome Pharmaceuticals Tom Waddell Pharma Solutions Scientist Perspectum Register Interest 2024 Event Program Partner in 2025